Dynavax Technologies (DVAX)

Jun 4, 2025, 4:59 PM EDT - 1 day ago

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 9:27 AM EDT - 2 days ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

May 28, 2025, 4:10 PM EDT - 8 days ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 23, 2025, 6:12 PM EDT - 13 days ago

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 1:54 PM EDT - 13 days ago

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:44 PM EDT - 13 days ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 21, 2025, 11:48 PM EDT - 15 days ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 15, 2025, 4:00 PM EDT - 21 days ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 12, 2025, 7:30 AM EDT - 25 days ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 7, 2025, 4:45 PM EDT - 4 weeks ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 6, 2025, 7:34 PM EDT - 4 weeks ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 4 weeks ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 8:00 AM EDT - 4 weeks ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 1, 2025, 8:00 AM EDT - 5 weeks ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Apr 29, 2025, 7:30 AM EDT - 5 weeks ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 22, 2025, 4:00 PM EDT - 6 weeks ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 21, 2025, 4:05 PM EDT - 6 weeks ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 17, 2025, 7:15 AM EDT - 7 weeks ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 16, 2025, 8:00 AM EDT - 7 weeks ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 3, 2025, 5:40 PM EDT - 2 months ago

Dynavax Files Preliminary Proxy Statement

Mar 10, 2025, 8:00 AM EDT - 3 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 6, 2025, 6:00 AM EST - 3 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 3, 2025, 5:58 PM EST - 3 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Feb 25, 2025, 4:10 PM EST - 3 months ago

Dynavax to Participate in Upcoming Investor Conferences

Feb 20, 2025, 6:38 PM EST - 3 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:01 PM EST - 3 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 19, 2025, 4:52 PM EST - 3 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 9:00 AM EST - 3 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 8:04 AM EST - 3 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 11, 2025, 3:11 PM EST - 4 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 6, 2025, 5:42 PM EST - 4 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Jan 27, 2025, 6:00 AM EST - 4 months ago

Dynavax Advances Board Refreshment Program

Jan 13, 2025, 9:00 AM EST - 5 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Nov 26, 2024, 4:05 PM EST - 6 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 6:36 PM EST - 7 months ago

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Nov 11, 2024, 8:00 AM EST - 7 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 7, 2024, 7:46 PM EST - 7 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 7 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:01 PM EST - 7 months ago

Dynavax Announces $200 Million Share Repurchase Program

Nov 6, 2024, 1:10 PM EST - 7 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Oct 29, 2024, 8:30 AM EDT - 7 months ago

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Oct 24, 2024, 4:10 PM EDT - 8 months ago

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Sep 25, 2024, 12:46 PM EDT - 9 months ago

3 'Repeatable' Biotech Trades

FOLD GSK NTLA XBI

Aug 23, 2024, 4:32 AM EDT - 10 months ago

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Aug 6, 2024, 8:54 PM EDT - 10 months ago

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:01 PM EDT - 10 months ago

Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

Jul 23, 2024, 4:00 PM EDT - 11 months ago

Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

Jun 27, 2024, 4:09 PM EDT - 1 year ago

Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program

May 28, 2024, 4:18 PM EDT - 1 year ago

Dynavax to Present at Upcoming Investor Conferences

May 14, 2024, 8:39 AM EDT - 1 year ago

US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine